13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • Research home > Beat Cancer Project > Biological characterisation and therapeutic options for high risk, DDX41 mutated, haematological malignancies

    Biological characterisation and therapeutic options for high risk, DDX41 mutated, haematological malignancies

    Dr Anna Brown

    Some families carry genetic changes that greatly increase their risk of developing blood cancers such as leukaemia. Using the latest DNA sequencing technologies, we have identified causal mutations in a gene called DDX41. How this gene causes blood cancer is unknown. In this proposal, we will examine functions of DDX41 in blood cells to determine how it works normally and how it causes leukaemia. We will also identify new targets for treating blood cancers with mutations in DDX41.



  • Apply for funding

    Apply for funding

    Find out more about applications for funding.

  • Cancer statistics

    Cancer statistics

    Access the latest cancer statistics for South Australia

  • Clinical trials

    Clinical trials

    Access the list of current clinical trials taking place in South Australia.